InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Curanex Pharmaceuticals Inc

CURX Clue Score33
United States Fiscal year ends December CIK 0002025942
$4.88 -8.10% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.88 +641.64% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 26 Aug 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2024Operating income−0.4Net income−0.4EPS, diluted−0.03Fiscal year 2025Operating income−4.2Net income−4.2EPS, diluted−0.17
FY2024FY2025
Operating income −0.4 −4.2
Net income −0.4 −4.2
Growth
EPS, diluted −0.03 −0.17

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2024Operating cash flow−0.6Fiscal year 2025Operating cash flow−10.5
FY2024FY2025
Operating cash flow −0.6 −10.5

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash and securities
Fiscal year 2024Shareholders’ equity0.5Fiscal year 2025Cash and securities5.0Shareholders’ equity11.2
FY2024FY2025
Cash and securities n/a 5.0
Shareholders’ equity 0.5 11.2

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2024 31 Dec 2024 FY2025 31 Dec 2025
Assets
n/a 5.0
0.5 11.6
Growth +2,135.8%
Liabilities
0.0 0.4
Equity
−0.6 −4.8
0.5 11.2
Growth +2,128.8%
Per share and net cash
24.0 28.3
calc 0.02 0.40

Lines marked calc are worked out here from filed figures; point at one for how.